These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 18834941

  • 41. Effect of rapamycin on cytokine profile in kidney transplant recipients treated with triple drug therapy.
    Morales-Buenrostro LE, Llorente L, Richaud-Patin Y, de Leo C, Soto-Vega E, Díaz-Alderete A, Vázquez-Lavista LG, Coto S, Correa-Rotter R, Alberú J.
    Transplant Proc; 2004; 36(6):1661-3. PubMed ID: 15350444
    [Abstract] [Full Text] [Related]

  • 42. Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation.
    Forgacs B, Merhav HJ, Lappin J, Mieles L.
    Transplant Proc; 2005 May; 37(4):1912-4. PubMed ID: 15919502
    [Abstract] [Full Text] [Related]

  • 43. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial.
    De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F.
    Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150
    [Abstract] [Full Text] [Related]

  • 44. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
    Prasad GV, Nash MM, Keough-Ryan T, Shapiro RJ.
    J Nephrol; 2010 Oct; 23(3):274-81. PubMed ID: 20383867
    [Abstract] [Full Text] [Related]

  • 45. CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation.
    Li Y, Shi Y, Huang Z, Bai Y, Niu Q, Cai B, Wang L, Feng W.
    Int Immunopharmacol; 2011 Dec; 11(12):2033-8. PubMed ID: 21911083
    [Abstract] [Full Text] [Related]

  • 46. Sirolimus monotherapy in liver transplantation.
    Di Benedetto F, Di Sandro S, De Ruvo N, Masetti M, Montalti R, Romano A, Guerrini GP, Ballarin R, De Blasiis MG, Gerunda GE.
    Transplant Proc; 2007 Dec; 39(6):1930-2. PubMed ID: 17692656
    [Abstract] [Full Text] [Related]

  • 47. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J, Ríos M G, Vignolo A P, Pinochet V C, Schultz M, Humeres A R, Delucchi A, Rius A M, Hepp K J.
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [Abstract] [Full Text] [Related]

  • 48. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts.
    Jiang H, Yang X, Soriano RN, Fujimura T, Krishnan K, Kobayashi M.
    Immunobiology; 2000 Sep; 202(3):280-92. PubMed ID: 11045663
    [Abstract] [Full Text] [Related]

  • 49. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.
    Moreno A, Bárcena R, García-Gonzalez M, García-Hoz F, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S.
    Transplant Proc; 2008 Dec; 40(10):3810-2. PubMed ID: 19100499
    [Abstract] [Full Text] [Related]

  • 50. Effects of ciclosporin A, tacrolimus and sirolimus on cytokine production in neonatal immune cells.
    Puzik A, Schultz C, Iblher P, Müller-Steinhardt M, Härtel C.
    Acta Paediatr; 2007 Oct; 96(10):1483-9. PubMed ID: 17880416
    [Abstract] [Full Text] [Related]

  • 51. Accuracy and variability of equations to estimate glomerular filtration rates in renal transplant patients receiving sirolimus and/or calcineurin inhibitor immunosuppression.
    Burke JT, Brault Y, Kahan BD, Hricik DE, Grinyó JM, Chapman JR, Polinsky M, Neylan JF.
    Transpl Int; 2008 May; 21(5):434-40. PubMed ID: 18194393
    [Abstract] [Full Text] [Related]

  • 52. Aggressive periodontitis and chronic arthritis: blood mononuclear cell gene expression and plasma protein levels of cytokines and cytokine inhibitors.
    Sørensen LK, Havemose-Poulsen A, Bendtzen K, Holmstrup P.
    J Periodontol; 2009 Feb; 80(2):282-9. PubMed ID: 19186969
    [Abstract] [Full Text] [Related]

  • 53. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine.
    Russ G, Jamieson N, Oberbauer R, Arias M, Murgia MG, Blancho G, Sato R, Stoeckl M, Revicki DA.
    Transpl Int; 2007 Oct; 20(10):875-83. PubMed ID: 17854445
    [Abstract] [Full Text] [Related]

  • 54. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors.
    San Segundo D, Fábrega E, López-Hoyos M, Pons F.
    Transplant Proc; 2007 Sep; 39(7):2290-2. PubMed ID: 17889166
    [Abstract] [Full Text] [Related]

  • 55. The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo.
    Libetta C, Sepe V, Zucchi M, Portalupi V, Meloni F, Rampino T, Dal Canton A.
    Kidney Int; 2007 Jul; 72(1):114-20. PubMed ID: 17410097
    [Abstract] [Full Text] [Related]

  • 56. Intrarenal vascular resistance parameters in kidney transplant patients receiving calcineurin inhibitor-based or sirolimus-based regimens.
    Lee PC, Lee CY, Hu RH, Lo C, Tsai MK, Lee PH.
    Nephrol Dial Transplant; 2010 May; 25(5):1675-80. PubMed ID: 20042398
    [Abstract] [Full Text] [Related]

  • 57. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection.
    Essa S, Raghupathy R, Pacsa AS, El-Shazly A, Said T, Azizieh F.
    J Med Virol; 2000 Feb; 60(2):223-9. PubMed ID: 10596025
    [Abstract] [Full Text] [Related]

  • 58. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells.
    Chang LY, Wan HC, Lai YL, Kuo YF, Liu TY, Chen YT, Hung SL.
    J Periodontal Res; 2009 Apr; 44(2):175-83. PubMed ID: 18973534
    [Abstract] [Full Text] [Related]

  • 59. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
    Rival-Tringali AL, Euvrard S, Decullier E, Claudy A, Faure M, Kanitakis J.
    Anticancer Res; 2009 Jun; 29(6):1927-32. PubMed ID: 19528449
    [Abstract] [Full Text] [Related]

  • 60. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients.
    Bucuvalas JC, Ryckman FC, Arya G, Andrew B, Lesko A, Cole CR, James B, Kotagal U.
    J Pediatr; 2005 Jun; 146(6):744-50. PubMed ID: 15973310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.